Phenominer Database Results (6 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
DA/Ztm experimental autoimmune encephalomyelitis duration spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56 days-103 days 9 9.0 d 2.67 8.0 in vivo visual assessment 0.0 0 69953 1258
DA/Ztm post-insult time to onset of experimental autoimmune encephalomyelitis spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56 days-103 days 9 13.0 d 2.0 6.0 in vivo visual assessment 0.0 0 69952 1258
DA/Ztm percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56 days-103 days 9 56.0 % in vivo visual assessment 0.0 0 69951 1258
DA/Ztm percentage of study population developing experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56 days-103 days 9 78.0 % in vivo visual assessment 0.0 0 69949 1258
DA/Ztm percentage of study population developing acute experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56 days-103 days 9 22.0 % in vivo visual assessment 0.0 0 69950 1258
DA/Ztm body weight gain spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 body mass male 56 days-103 days 9 32.0 g 8.33 25.0 body weighing method 0.0 0 69948 1258